Further experience with polydioxanone airway stents in children

Rocío Morante-Valverde1, María López Díaz1, Mª Carmen Luna-Paredes2

  • 1Pediatric Surgery Division & Pediatric Airway Unit, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain.

PubMed

Insights

Biodegradable polydioxanone (PDO) airway stents are safe and effective for treating severe pediatric tracheobronchial obstruction. Further research is needed on managing granulation tissue and optimizing degradation times for these airway stents.

Area of Science:

  • Pediatric Pulmonology
  • Biomaterials Science
  • Medical Device Engineering

Background:

  • Severe central airway obstruction in children presents significant management challenges.
  • Biodegradable polydioxanone (PDO) stents offer a potential solution for pediatric airway issues.
  • Experience with PDO stents in pediatric populations requires ongoing evaluation for safety and efficacy.

Purpose of the Study:

  • To update the clinical experience with biodegradable polydioxanone (PDO) airway stents in pediatric patients.
  • To assess the effectiveness and safety of PDO stents in managing severe tracheobronchial obstruction.
  • To identify factors influencing outcomes in children treated with PDO airway stents.

Main Methods:

  • Retrospective analysis of pediatric patients treated with PDO stents between 2012 and 2023.
  • Collection of data on patient demographics, comorbidities, stent characteristics, and clinical outcomes.
  • Statistical analysis to determine the impact of various factors on treatment outcomes.

Main Results:

  • Fifty-four PDO stents were placed in 26 children with severe airway obstruction (tracheomalacia, bronchomalacia, stenosis).
  • Complete resolution occurred in 30.7% of patients, with partial improvement in 50%.
  • Younger age and smaller stent size correlated with better outcomes; granulation tissue was the most common complication.

Conclusions:

  • Biodegradable polydioxanone (PDO) airway stents are safe and effective for severe pediatric tracheobronchial obstruction.
  • Granulation tissue formation remains a significant complication requiring further investigation.
  • Optimization of PDO stent degradation profiles and management of complications warrant future research.
Abstract